The unique and innovative OMNIBotics® Active Spacer robotic tissue balancing device, designed and developed by OMNIlife science, Inc., received FDA 510(k) clearance in September 2017. This new technology provides the surgeon with a quantitative tool to actively manage the soft tissue envelope with dynamic real-time feedback. When combined with the accuracy of alignment and bone cuts provided by the OMNIBotics system, the result is a completely customized procedure from both a skeletal perspective as well as a soft tissue perspective. The OMNIBotics system is cleared for use in combination with the Apex™ Knee System for total knee replacement. The full press release is available here.

Dr. Jeffrey Lawrence, an orthopedic surgeon on the staff of the Gundersen Viroqua Clinic who also does surgeries at Vernon Memorial, recently used an OMNIBotics Active Spacer robotic tissue balancing device to help replace a 66-year-old retiree’s right knee in October. For more information see the news article “Genoa woman steps more lively after new device helps replace knee” by Mike Tighe, La Crosse Tribune, here.

OMNI reported successful completion of the first 100 Apex Knee System total knee replacements utilizing the OMNIBotics Active Spacer on December 7, 2017. The full press release is available here.